Intrinsic Value of S&P & Nasdaq Contact Us

Nutriband Inc. NTRB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Nutriband Inc. (NTRB) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

Analysts estimate Earnings Per Share (EPS) of $-0.23 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.99 vs est $-0.23 (missed -330.4%). Analyst accuracy: 23%.

NTRB Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Nutriband Inc. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — NTRB

23%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$0.99 vs Est –$0.23 ▼ 76.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — NTRB

46%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $0.002B vs Est $0.003B ▼ 54.2% off
Revenue Trend
Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message